Prolonged Carotid Sinus Reflex Is a Risk Factor for Contrast-Induced Nephropathy following Carotid Artery Stenting

References

1. 1.↵
   1. Rihal CS,
   2. Textor SC,
   3. Grill DE,
   4. et al

   . Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259–64

   Abstract/FREE Full Text
2. 2.↵
   1. Levy EM,
   2. Viscoli CM,
   3. Horwitz RI

   . The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996;275:1489–94

   CrossRefPubMedWeb of Science
3. 3.↵
   1. McCullough PA,
   2. Wolyn R,
   3. Rocher LL,
   4. et al

   . Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368–75

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Nash K,
   2. Hafeez A,
   3. Hou S

   . Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930–36

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Gleeson TG,
   2. Bulugahapitiya S

   . Contrast-induced nephropathy. AJR Am J Roentgenol 2004;183:1673–89

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Fishbane S,
   2. Durham JH,
   3. Marzo K,
   4. et al

   . N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004;15:251–60

   Abstract/FREE Full Text
7. 7.↵
   1. Maeder M,
   2. Klein M,
   3. Fehr T,
   4. et al

   . Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 2004;44:1763–71

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Taliercio CP,
   2. Vlietstra RE,
   3. Fisher LD,
   4. et al

   . Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104:501–04

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Freeman RV,
   2. O'Donnell M,
   3. Share D,
   4. et al

   . Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002;90:1068–73

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Lindsay J,
    2. Canos DA,
    3. Apple S,
    4. et al

    . Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine. Am J Cardiol 2004;94:786–89

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Mehran R,
    2. Aymong ED,
    3. Nikolsky E,
    4. et al

    . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393–99

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Dangas G,
    2. Laird JR Jr.,
    3. Satler LF,
    4. et al

    . Postprocedural hypotension after carotid artery stent placement: predictors and short- and long-term clinical outcomes. Radiology 2000;215:677–83

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Leisch F,
    2. Kerschner K,
    3. Hofmann R,
    4. et al

    . Carotid sinus reactions during carotid artery stenting: predictors, incidence, and influence on clinical outcome. Catheter Cardiovasc Interv 2003;58:516–23

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Gupta R,
    2. Abou-Chebl A,
    3. Bajzer CT,
    4. et al

    . Rate, predictors, and consequences of hemodynamic depression after carotid artery stenting. J Am Coll Cardiol 2006;47:1538–43

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Lin PH,
    2. Zhou W,
    3. Kougias P,
    4. et al

    . Factors associated with hypotension and bradycardia after carotid angioplasty and stenting. J Vasc Surg 2007;46:846–53, discussion 53–54

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Taha MM,
    2. Toma N,
    3. Sakaida H,
    4. et al

    . Periprocedural hemodynamic instability with carotid angioplasty and stenting. Surg Neurol 2008;70:279–85, discussion 85–86

    CrossRefPubMed
17. 17.↵
    Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991;325:445–53

    CrossRefPubMedWeb of Science
18. 18.↵
    Endarterectomy for asymptomatic carotid artery stenosis: Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995;273:1421–28

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Hobson RW 2nd.,
    2. Brott TG,
    3. Roubin GS,
    4. et al

    . Carotid artery stenting: meeting the recruitment challenge of a clinical trial. Stroke 2005;36:1314–15

    FREE Full Text
20. 20.↵
    1. Rudnick MR,
    2. Berns JS,
    3. Cohen RM,
    4. et al

    . Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism—a critical review. Am J Kidney Dis 1994;24:713–27

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Matsuo S,
    2. Imai E,
    3. Horio M,
    4. et al

    . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–92

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Tamakawa N,
    2. Sakai H,
    3. Nishimura Y

    . Evaluation of carotid artery plaque using IVUS virtual histology. Interv Neuroradiol 2007;13(suppl 1):100–05. Epub 2007 Jun 27

    Abstract/FREE Full Text
23. 23.↵
    1. Cigarroa RG,
    2. Lange RA,
    3. Williams RH,
    4. et al

    . Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649–52

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Krol AL,
    2. Dzialowski I,
    3. Roy J,
    4. et al

    . Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography. Stroke 2007;38:2364–66

    Abstract/FREE Full Text
25. 25.↵
    1. Dittrich R,
    2. Akdeniz S,
    3. Kloska SP,
    4. et al

    . Low rate of contrast-induced nephropathy after CT perfusion and CT angiography in acute stroke patients. J Neurol 2007;254:1491–97

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Hopyan JJ,
    2. Gladstone DJ,
    3. Mallia G,
    4. et al

    . Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke. AJNR Am J Neuroradiol 2008;29:1826–30

    Abstract/FREE Full Text
27. 27.↵
    1. Mehdiratta M,
    2. Schlaug G,
    3. Kumar S,
    4. et al

    . Reducing the delay in thrombolysis: is it necessary to await the results of renal function tests before computed tomography perfusion and angiography in patients with code stroke? J Stroke Cerebrovasc Dis 2008;17:273–75

    CrossRefPubMed
28. 28.↵
    1. Lima FO,
    2. Lev MH,
    3. Levy RA,
    4. et al

    . Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. AJNR Am J Neuroradiol 2010;31:817–21. Epub 2009 Dec 31

    Abstract/FREE Full Text
29. 29.↵
    1. Oleinik A,
    2. Romero JM,
    3. Schwab K,
    4. et al

    . CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke 2009;40:2393–97

    Abstract/FREE Full Text
30. 30.↵
    1. Loh Y,
    2. McArthur DL,
    3. Vespa P,
    4. et al

    . The risk of acute radiocontrast-mediated kidney injury following endovascular therapy for acute ischemic stroke is low. AJNR Am J Neuroradiol 2010;31:1584–87. Epub 2010 Jun 3

    Abstract/FREE Full Text
31. 31.↵
    1. Campbell DR,
    2. Flemming BK,
    3. Mason WF,
    4. et al

    . A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography. Can Assoc Radiol J 1990;41:133–37

    PubMed
32. 32.↵
    1. Moore RD,
    2. Steinberg EP,
    3. Powe NR,
    4. et al

    . Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992;182:649–55

    CrossRefPubMedWeb of Science
33. 33.↵
    1. McCullough PA

    . Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51:1419–28

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Lavoie P,
    2. Rutledge J,
    3. Dawoud MA,
    4. et al

    . Predictors and timing of hypotension and bradycardia after carotid artery stenting. AJNR Am J Neuroradiol 2008;29:1942–47

    Abstract/FREE Full Text
35. 35.↵
    1. Park BD,
    2. Divinagracia T,
    3. Madej O,
    4. et al

    . Predictors of clinically significant postprocedural hypotension after carotid endarterectomy and carotid angioplasty with stenting. J Vasc Surg 2009;50:526–33

    CrossRefPubMed
36. 36.↵
    1. Trocciola SM,
    2. Chaer RA,
    3. Lin SC,
    4. et al

    . Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting. J Vasc Surg 2006;43:714–20

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Persson PB,
    2. Hansell P,
    3. Liss P

    . Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005;68:14–22

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Morikawa S,
    2. Sone T,
    3. Tsuboi H,
    4. et al

    . Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. J Am Coll Cardiol 2009;53:1040–46

    CrossRefPubMed
39. 39.↵
    1. Lindsay J,
    2. Apple S,
    3. Pinnow EE,
    4. et al

    . Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 2003;59:338–43

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Marenzi G,
    2. Assanelli E,
    3. Campodonico J,
    4. et al

    . Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009;150:170–77

    CrossRefPubMedWeb of Science